Senti.png
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at ASGCT 24th Annual Meeting
May 11, 2021 08:00 ET | Senti Bio
- Using Logic Gating gene circuits, Senti Bio is engineering allogeneic CAR-NK cells to target and more precisely eliminate cancer cells while sparing healthy cells - - Using a Regulator Dial...
Senti.png
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at Upcoming Scientific Conferences
April 21, 2021 16:00 ET | Senti Bio
SOUTH SAN FRANCISCO, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Senti Bio, a leading gene circuit company, today announced the acceptance of five abstracts for presentation at upcoming virtual...
Senti.png
Senti Bio Enters Collaboration with Spark Therapeutics to Develop Next-Generation Precision Gene Therapies
April 13, 2021 08:30 ET | Senti Bio
- Collaboration combines Senti Bio’s leading-edge gene circuit technology platform and high-throughput synthetic promoter design capabilities with Spark Therapeutics’ investigational gene therapies...
Senti.png
Senti Bio Presents Preclinical Data from CAR-NK Cell Programs at AACR Virtual Annual Meeting
April 12, 2021 08:30 ET | Senti Bio
SOUTH SAN FRANCISCO, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Senti Bio, a leading gene circuit company, today announced that results from its discovery-stage oncology program using allogeneic...
Senti.png
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at Upcoming Scientific Conference
March 12, 2021 10:00 ET | Senti Bio
- AACR abstract to highlight the Company’s progress with proprietary gene circuit engineered allogeneic CAR-NK cell therapy pipeline - SOUTH SAN FRANCISCO, Calif., March 12, 2021 (GLOBE NEWSWIRE)...
Senti.png
Senti Bio to Participate in Upcoming Investor Conferences
February 11, 2021 10:00 ET | Senti Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Senti Bio, a leading gene circuit company, today announced that company leadership will participate in two upcoming investor...
Senti.png
Senti Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 07, 2021 05:00 ET | Senti Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Senti Bio, a leading gene circuit company, today announced that Dr. Tim Lu, the CEO of Senti Bio, will present a corporate overview at...